Clinical trial

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

NCT00148642 · C. R. Bard, Industry · Completed

Key facts

NCT number NCT00148642
Title Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Official title Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Acronym NASCENT
Lead sponsor C. R. Bard, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Respiratory Failure
Intervention type Device
Interventions silver salts coated endotracheal tube, uncoated endotracheal tube
Enrollment 2,003
Start date Nov 1, 2002
Primary completion Mar 1, 2006
Completion Mar 1, 2006
First posted Sep 8, 2005
Last update posted Jan 18, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies